Literature DB >> 17900879

Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems.

Luciana B Lopes1, Fernanda F F Speretta, M Vitória L B Bentley.   

Abstract

Application of vitamin K (vitK) to the skin has been used for suppression of pigmentation and resolution of bruising. However, there is no report concerning the extent of its penetration in the skin. In this study, we investigated the in vitro skin penetration and transdermal delivery of vitK, and whether these parameters may be enhanced by lipid-based drug delivery systems. The lipid formulation used in this study contains monoolein (MO), which is structured as a liquid crystalline phase, named hexagonal phase. The skin penetration of vitK was assessed in vitro using porcine ear skin mounted in a Franz diffusion cell. VitK (2.5%, w/w) was incorporated in either of three formulations: liquid vaseline, MO-based hexagonal phase gel (MO-vitK-water at 77.5/2.5/20, w/w/w) and MO-based nanodispersion of hexagonal phase (MO-vitK-poloxamer-water at 15/2.5/0.9/81.6, w/w/w/w). When vaseline was used, vitK was delivered mainly to the stratum corneum (SC): 9.50+/-0.97 microg/cm(2) of vitK was delivered to the SC at 12 h post-application, whereas 4.90 +/- 1.28 microg/cm(2) of vitK was delivered to the epidermis (E)+dermis (D) at the same time point. The hexagonal phase gel and the nanodispersion delivered approximately 2 times more vitK to the SC and 2.0-3.7 times more vitK to the [E+D] than the vaseline solution. The nanodispersion (but not the gel) also increased the transdermal delivery of vitK at 9 h ( approximately 3-fold increase). These results demonstrate that the topical delivery of vitK incorporated in a lipophilic vehicle is small, but it may be enhanced by MO-based systems, which might be useful to increase the effectiveness of topical vitK therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900879     DOI: 10.1016/j.ejps.2007.07.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  15 in total

1.  Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.

Authors:  Jesper Grau Eriksen; Inger Kaalund; Ole Clemmensen; Jens Overgaard; Per Pfeiffer
Journal:  Support Care Cancer       Date:  2017-02-15       Impact factor: 3.603

2.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

3.  Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.

Authors:  Shun Han; Jin-qiu Shen; Yong Gan; Hai-ming Geng; Xin-xin Zhang; Chun-liu Zhu; Li Gan
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

4.  Nanocarriers to Enhance the Accumulation of Vitamin K1 into the Skin.

Authors:  Virginia Campani; Marco Biondi; Laura Mayol; Francesco Cilurzo; Silvia Franzé; Michele Pitaro; Giuseppe De Rosa
Journal:  Pharm Res       Date:  2015-11-30       Impact factor: 4.200

5.  A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast Tissue.

Authors:  Giovanna C Salata; Isabella D Malagó; Luciana B Lopes
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

6.  Novel lecithin-integrated liquid crystalline nanogels for enhanced cutaneous targeting of terconazole: development, in vitro and in vivo studies.

Authors:  Yosra Sr Elnaggar; Sara M Talaat; Mohammed Bahey-El-Din; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2016-10-25

Review 7.  Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.

Authors:  Rajan Rajabalaya; Muhammad Nuh Musa; Nurolaini Kifli; Sheba R David
Journal:  Drug Des Devel Ther       Date:  2017-02-13       Impact factor: 4.162

8.  Development of a liposome-based formulation for vitamin K1 nebulization on the skin.

Authors:  Virginia Campani; Dario Marchese; Maria Teresa Pitaro; Michele Pitaro; Paolo Grieco; Giuseppe De Rosa
Journal:  Int J Nanomedicine       Date:  2014-04-10

Review 9.  Cubic and hexagonal liquid crystals as drug delivery systems.

Authors:  Yulin Chen; Ping Ma; Shuangying Gui
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

10.  Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding.

Authors:  Aaron R J Hutton; Helen L Quinn; Paul J McCague; Courtney Jarrahian; Annie Rein-Weston; Patricia S Coffey; Emily Gerth-Guyette; Darin Zehrung; Eneko Larrañeta; Ryan F Donnelly
Journal:  Int J Pharm       Date:  2018-02-19       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.